Verona Pharma plc【VRNA】

Market cap

$72.8B

P/E ratio

	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Cash and cash equivalents	188	148	228	272	400
Accounts receivable, net	-	-	-	-	31
Prepaid expenses	5	4	2	4	8
Tax incentive receivable	8	16	9	11	6
Inventory	-	-	-	-	6
Other current assets	2	2	3	3	3
Total current assets	203	170	243	290	454
Furniture and equipment, net	0	0	0	0	1
Inventory, long-term	-	-	-	-	2
Goodwill	1	1	1	1	1
Equity interest	-	15	15	15	15
Right-of-use assets	1	1	1	3	2
Total non-current assets	2	17	16	18	21
Total assets	204	187	259	308	474
Accounts payable	0	10	3	3	11
Accrued expenses	11	22	14	4	17
Royalties payable	-	-	-	-	1
Royalties payable	-	-	-	-	1
Current operating lease liabilities	1	1	1	1	1
Taxes payable	-	0	0	-	9
Other current liabilities	0	0	1	0	3
Total current liabilities	14	33	19	9	43
Term loan	5	5	10	48	120
Revenue interest purchase and sale agreement	-	-	-	-	105
Operating Lease, Liability, Noncurrent	1	0	0	2	1
Total non-current liabilities	5	5	10	50	227
Total liabilities	19	39	29	59	270
Common Stock, Value, Issued	32	32	41	43	45
Additional paid-in capital	366	385	529	601	728
Ordinary shares held in treasury	2	1	2	2	2
Accumulated other comprehensive loss	-5	-5	-5	-5	-5
Accumulated deficit	-207	-264	-333	-388	-562
Total shareholders' equity	185	148	230	249	205
Total liabilities and shareholders' equity	204	187	259	308	474